Physician profile
Ruby Judith Maloco Garzon
NPI 1942819636
$1,129.87
in general payments reported to CMS, 2019-2025
18 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.02 · 2022: $50.80 · 2023: $224 · 2024: $424 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $234.01 | 2024-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.08 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $102.16 | 2024-2025 | Farxiga |
| Amgen INC. | $90.55 | 2022-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $80.20 | 2025 | |
| Exact Sciences Corporation | $58.48 | 2023-2025 | Cologuard Collection Kit |
| Medicomp INC | $50.05 | 2025 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $42.61 | 2025 | Amvuttra |
| Cequr Corporation | $42.39 | 2024 | Cequr Simplicity |
| Pfizer INC. | $41.79 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $35.72 | 2023 | Assure Wcd |
| Glaxosmithkline, LLC. | $26.04 | 2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $25.85 | 2024 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $23.91 | 2025 | |
| Heartflow, INC. | $21.15 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.50 | 2024 | |
| Bridgebio Pharma, INC. | $15.77 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $14.61 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Judith Garzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.